Analysts: PC Decline Hurts Microsoft’s Outlook and 2 Other Research Notes To Look Into

Microsoft (NASDAQ:MSFT): Pacific Crest is worried about the company’s outlook, which it believes is worrisome due to the decline in PC demand. It continues to view the stock as a decent value, and keeps a Sector Perform rating on the shares.

EXCLUSIVE OFFER! Take Advantage of the Tax Relief 50% Off Sale for a Limited Time. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

MSFT

Vertex (NASDAQ:VRTX): After positive results from Vertex’s Pase II trial of the Kalydeco/VX-661 combo treatment for cystic fibrosis, Wells Fargo maintains that the data should improve the risk profile of the company’s entire cystic fibrosis franchise. The firm raised its valuation range on the shares to $90-$94, up from $62-$64, and maintains an Outperform rating.

EXCLUSIVE OFFER! Take Advantage of the Tax Relief 50% Off Sale for a Limited Time. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

VRTX

ExactTarget (NYSE:ET): Channel checks reveal that Pardot, a recent acquisition of ExactTarget, has added many customers and outperformed in Q1, according to Barrington, which keeps its $30 price target and Outperform on the stock.

EXCLUSIVE OFFER! Take Advantage of the Tax Relief 50% Off Sale for a Limited Time. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

ET

Don’t Miss: Did Windows Save Microsoft This Quarter?

More from The Cheat Sheet